Ann: Appendix 4C Quarterly (Q2 2023) and Business Update, page-18

First 18 Last

Share
Profile

Follow
RockstarJones

13,592 Posts.

462

28/07/23

19:27

Post #: 69046948
Share

Originally posted by Shortblack: ↑

Cost Savings (compared with June 22)
R & D and Manufacturing $1.1mil
Wages & Corp Costs $1.7mil

Manufacturing The company has not manufactured any product for 12 months. In the last 6 months they seem to have only sold around 1/3 of the stock on hand as at end of December 2022 ... ONE THIRD!!!

Corporate Costs These are mostly legal and consulting fees associated with ongoing investigations by ASIC and AFP.

Cash Flow Positive Let's look at this ......
If the company manages to double the sales (the remainder of existing product on hand) and receives all funds over the next 6 months, it will bring in around $3mil.
If the company manages to keep quarterly costs the same, it will spend at least $3.5mil.

There is nothing in this update that suggests they are capable of doubling their sales and income in the next 6 months.
The company has warned that the end result of the ongoing investigations risk costing the company a lot of money - in legal fees, fines, penalties etc.

I cannot see any sign of the company becoming cashflow positive based on this report.

What I see is that at the end of the year the company will have around $7 - $8mil in the bank (much less if investigations are finalised this year), minimal stock (most of which will be so old it will be written off), and Zero assets.

They are telling you in this report that time is running out for them.

The shorters must be laughing - they know how PET investors behave.

Expand

there are no shorters on PET

PET Price at posting: 2.6¢ Sentiment: Hold Disclosure: Held
6 Upvote

0 Great analysis

Reply

Top Stories

AUG

Augustus sees imperial share rise on high-grade Cu and gold results at Ti-Tree

TX3

Canadian fieldwork yields multiple pegmatites for Trinex

I88

Infini soars 50% as company reveals it could’ve just made uranium history – redefining what it means to be “high grade”

TLX

Telix jumps 11.6% as US government indicates proposed medicare changes won't affect prostate cancer drug

RNU

Renascor wins a funding boost given it wants to produce a critical mineral – but $5M award pales in comparison to some

There are more pages in this discussion • 21 more messages in this thread...

First 18 Last

Add PET (ASX) to my watchlist

(20min delay)
Last 2.5¢		Change 0.000(0.00%)		Mkt cap ! $15.60M

Open	High	Low	Value	Volume
0.0¢	0.0¢	0.0¢	$0	0

Ann: Appendix 4C Quarterly (Q2 2023) and Business Update, page-18

Augustus sees imperial share rise on high-grade Cu and gold results at Ti-Tree

Canadian fieldwork yields multiple pegmatites for Trinex

Infini soars 50% as company reveals it could’ve just made uranium history – redefining what it means to be “high grade”

Telix jumps 11.6% as US government indicates proposed medicare changes won't affect prostate cancer drug

Renascor wins a funding boost given it wants to produce a critical mineral – but $5M award pales in comparison to some

Featured News

Featured News

Ann: Appendix 4C Quarterly (Q2 2023) and Business Update, page-18

Top Stories

Augustus sees imperial share rise on high-grade Cu and gold results at Ti-Tree

Canadian fieldwork yields multiple pegmatites for Trinex

Infini soars 50% as company reveals it could’ve just made uranium history – redefining what it means to be “high grade”

Telix jumps 11.6% as US government indicates proposed medicare changes won't affect prostate cancer drug

Renascor wins a funding boost given it wants to produce a critical mineral – but $5M award pales in comparison to some

Featured News

Featured News